We're buying more shares of this healthcare company amid an overblown sell-off
Shortly after the opening bell, we will purchase 140 shares of Abbott Laboratories at approximately $112. Following the deal, Jim…
investment strategy
Nvidia tramples the bears. Jim Cramer on struggling stocks Starbucks and Abbott
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Jim Cramer defends Elon Musk's use of ketamine for depression
CNBC's Jim Cramer said Tuesday that Elon Musk's revelation that he takes prescription ketamine for depression was brave and “saved…
Where cracks may appear in the banking sector without more mergers and acquisitions
Traders work at the New York Stock Exchange (NYSE) in New York City, U.S., on February 7, 2024. Brendan Mcdermid…
Disney scores a victory in the Nelson Peltz board fight. 2 other portfolio stocks recover
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
It's not too late to buy Abbott stock after Friday's sell-off
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Morgan Stanley names head of artificial intelligence, Jeff McMillan
The Morgan Stanley digital sign is seen at the company's headquarters in Times Square in New York, U.S., on Friday,…
Weight Loss ETFs May Avoid Obesity Drug Craze, Experts Say
There may be more reasons to invest in individual stocks than exchange-traded funds in the weight loss space. Amplify ETF…
News Coming to GE Healthcare (GEHC) Eliminates Excess Stock
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Family offices tripled, creating a new gold rush on Wall Street
Westend61 | Westend61 | fake images A version of this article first appeared in CNBC's Inside Wealth newsletter with Robert…